Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases
- Supplementary File 1:
PDF-Document (PDF, 160 KiB)
Möhn, N.; Konen, F.F.; Pul, R.; Kleinschnitz, C.; Prüss, H.; Witte, T.; Stangel, M.; Skripuletz, T. Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases. J. Clin. Med. 2020, 9, 4067. https://doi.org/10.3390/jcm9124067
Möhn N, Konen FF, Pul R, Kleinschnitz C, Prüss H, Witte T, Stangel M, Skripuletz T. Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases. Journal of Clinical Medicine. 2020; 9(12):4067. https://doi.org/10.3390/jcm9124067
Chicago/Turabian StyleMöhn, Nora; Konen, Franz F.; Pul, Refik; Kleinschnitz, Christoph; Prüss, Harald; Witte, Torsten; Stangel, Martin; Skripuletz, Thomas. 2020. "Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases" J. Clin. Med. 9, no. 12: 4067. https://doi.org/10.3390/jcm9124067